<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Groundbreaking Copper Drug Could Boost Memory by 44 Percent, a Breakthrough in Treating Cognitive Decline — Live Feed</title><link>https://www.live-feeds.com/feed/groundbreaking-copper-drug-could-boost-memory-by-44-percent-a-breakthrough-in-treating-cognitive-decline</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/groundbreaking-copper-drug-could-boost-memory-by-44-percent-a-breakthrough-in-treating-cognitive-decline/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>Copper Drug Cu(ATSM) Reduces Alzheimer's Proteins and Improves Memory</title><link>https://www.live-feeds.com/feed/groundbreaking-copper-drug-could-boost-memory-by-44-percent-a-breakthrough-in-treating-cognitive-decline</link><guid isPermaLink="false">https://www.live-feeds.com/feed/groundbreaking-copper-drug-could-boost-memory-by-44-percent-a-breakthrough-in-treating-cognitive-decline#u9908</guid><pubDate>Tue, 23 Jun 2026 14:06:05 +0000</pubDate><description>Monash University researchers found that the copper-based compound Cu(ATSM) restores the brain&amp;#039;s ability to clear toxic proteins. Laboratory experiments show the drug reduces amyloid buildup and improves spatial memory. The compound has previously been tested in humans for other neurological conditions.What's confirmed:The copper-based compound Cu(ATSM) reduced amyloid-beta by 42%Cu(ATSM) improved spatial memory by 44% in Alzheimer&amp;#039;s modelsThe drug increased the brain&amp;#039;s P-gp pumps by 24%Cu(ATSM) has already been tested in humans for other neurological conditionsResearch from Mon</description></item>
</channel></rss>